Q5168 Medicaid reimbursement rate by state (2026)
Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg. Medicaid pays a median of $246.59 for Q5168 across 14 states, from $26.38 in South Dakota to $307.04 in Arkansas.
Data as of 2026-10-05. Every rate links to the official document it came from.
- States publishing
- 14
- National median
- $246.59units vary by state
- Lowest
- $26.38South Dakota
- Highest
- $307.04Arkansas
What does Medicaid pay for Q5168?
14 state Medicaid programs publish a fee-for-service rate for Q5168 at the physician psychologist level. The national median is $246.59 (units differ between states). Arkansas pays the most, $307.04, and South Dakota the least, $26.38, a 11.6x spread.
Q5168 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 14 states with every variant, modifier and effective date.
Frequently asked questions
What does Medicaid pay for Q5168?
It depends on the state. Of the 14 states with a published fee-for-service rate, the median is $246.59. Arkansas pays the most ($307.04) and South Dakota the least ($26.38).
Which state pays the highest Medicaid rate for Q5168?
Arkansas, at $307.04, effective 2026-08-10.
Do managed-care plans pay the same rate for Q5168?
Not necessarily. Each state's plan contracts decide whether plans must pay at least the fee-for-service rate, pay a state-set rate, or negotiate their own. The workspace shows the rule for each state, cited to the contract or statute.